Additionally, the in vivo results confirmed that this tumor-suppressing effect was not only due to TRAIL-induced apoptosis but also involved the inhibition of angiogenesis, as shown by decreased levels of pro-angiogenic cytokines, including VEGF-A, IL6, and IL8 [63]. The gene discussed is TNFSF10; the disease is neoplasm.